Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Tiziana Life Sciences Ltd (TLSA)
Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tiziana Life Sciences Ltd 14-15 Conduit Street LONDON X0 W1S 2XJ GBR

www.tizianalifesciences.com P: 44-20-7495-2379

Description:

Tiziana Life Sciences PLC is a biotechnology company. It focuses on the clinical development for the treatment of cancers, chronic inflammatory and autoimmune neurodegenerative disorders. The company's product pipeline consists of Foralumab TZLS-401 and Milciclib TZLS-201 which are in clinical stage. Tiziana Life Sciences PLC is based in London, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 48,067
Enterprise Value, $K 29,947
Shares Outstanding, K 102,270
Annual Sales, $ 0 K
Annual Net Income, $ -15,400 K
EBIT, $ 0 K
EBITDA, $ -14,540 K
60-Month Beta 0.83
% of Insider Shareholders 39.82%
% of Institutional Shareholders 0.85%
Float, K 61,546
% Float 60.18%
Short Volume Ratio 0.66

Growth:

1-Year Return -7.86%
3-Year Return -83.62%
5-Year Return -53.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -650.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 04/24/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 5-2 on 07/31/20

TLSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.70
Book Value/Share 0.13
Interest Coverage -1,539.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar